Ben Kong

Ben Kong

University of Sydney - Sydney / Australia
Medical and Health Sciences / Immunology
AD Scientific Index ID: 41870
person_outline Ben Kong's MOST POPULAR ARTICLES
1-) Pneumonitis in patients treated with anti–programmed death-1/programmed death ligand 1 therapy Journal of Clinical Oncology 35 (7), 709-717, 2017
2-) Cutaneous adverse events (AEs) of anti-programmed cell death (PD)-1 therapy in patients with metastatic melanoma: a single-institution cohort Journal of the American Academy of Dermatology 74 (3), 455-461. e1, 2016
3-) Dynamic changes in PD-L1 expression and immune infiltrates early during treatment predict response to PD-1 blockade in melanoma Clinical Cancer Research 23 (17), 5024-5033, 2017
4-) Standard-dose pembrolizumab in combination with reduced-dose ipilimumab for patients with advanced melanoma (KEYNOTE-029): an open-label, phase 1b trial The Lancet Oncology 18 (9), 1202-1210, 2017
5-) Dynamic changes in PD-L1 expression and immune infiltrates early during treatment predict response to PD-1 blockade in melanoma Clinical Cancer Research 23 (17), 5024-5033, 2017